Chloroquine, an anti-malarial drug, restricted glioma cell proliferation via suppression of TGF-β activity as well as expression of plasminogen activator inhibitor-1 (PAI-1) and vascular endothelial growth factor A (VEGF-A) [203]. The gene discussed is TGFB1; the disease is glioma.